Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

Cipla Limited is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and ...

Cipla is currently priced at Rs 1511.40, showing a decline of 0.26% today. The 3-day exponential moving average stands at Rs 1515.16. Cipla is currently valued at Rs 1513.7, experiencing a small drop ...

Return on investment - most recent fiscal year 16.16 ...

The American Lung Association in New York is proud to welcome Cipla back as the lead sponsor of the 2025 LUNG FORCE Walk New York City. As this year’s Breathe Free Sponsor, Cipla continues its ...

Cipla Foundation, along with CanSupport, have expanded free palliative home care services in Pune. With nine dedicated home care teams, the initiative will provide supportive care to more than 900 ...

India’s third-largest drug manufacturer, Cipla, has been barred from using a trademark name for an antibiotic drug after a South African court found it too similar to that of a competing product ...

Stock Market Alert: Nifty, Sensex Open on Shaky Ground: Who’s Winning and Who’s Losing Today?

Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the manufacturing facility of Medispray Laboratories Private Limited, a ...

New Delhi: The pharmaceutical major Cipla has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) for conducting Phase III ...

In partnership with CanSupport, a WHO-recognised NGO, Cipla Foundation has launched comprehensive free-of-charge palliative home care services in Pune. With nine dedicated home care teams, the ...